NBA.com's John Schuhmann shared the Sixers' statement about the 2017 No. 1 overall draft pick, with Philadelphia saying its medical staff will evaluate Fultz again in about three weeks:
While Saturday's update provided a little good news regarding Fultz, the absence of a definitve timetable for his recovery was a cause for concern.
Even assuming the best-case scenario that Fultz will be healthy enough to play when doctors look at him in three weeks, he will have missed most of the first half of the 2017-18 regular season. So far, he has appeared in 76 minutes over four games.
Given how Fultz's first year in the NBA has unfolded, expecting him to come back by the start of January may be overly optimistic.
The Sixers don't have much reason to rush him back, either. If anything, the team's experiences with Joel Embiid and Ben Simmons illustrated the benefits of being cautious with the health of young players.
Simmons missed his entire rookie season, while Embiid didn't play in his first two years. Those setbacks haven't seemed to hurt the on-court development of either player. Simmons is the favorite to win Rookie of the Year, while Embiid is averaging 23.5 points and 11.1 rebounds per game.
Should the next update on Fultz also provide little clarity about his possible return, it may not be a bad idea for the Sixers to consider shutting him down.